Table of Content

1. Introduction


2. Research Methodology


3. Executive Summary


4. Market Dynamics

4.1 Growth Drivers
4.2 Challenges


5. Saudi Arabia

5.1 Population
5.2 Per Capita Healthcare Expenses
5.3 Healthcare Expenditure


6. Saudi Arabia IVD Market


7. Market Share

7.1 By Segments
7.2 By Disease


8. Segments – Saudi Arabia IVD Market

8.1 Clinical Chemistry
8.2 Immunoassy
8.3 Molecular diagnostics
8.4 Hematology
8.5 Microbiology
8.6 Coagulation and Hemostasis
8.7 Urinalysis
8.8 Others


9. Disease Type – Saudi Arabia IVD Market

9.1 Infectious
9.2 Cardiology
9.3 Diabetes
9.4 Cancer/Oncology
9.5 Other Application


10. End Users – Saudi Arabia IVD Market

10.1 Public Labs& Hospitals
10.2 Private Labs& Hospitals
10.3 Others


11. Company Analysis

11.1 Roche Diagnostics

11.1.1 Overview
11.1.2 Company Initiatives
11.1.3 Sales Analysis

11.2 Abbott

11.2.1 Overview
11.2.2 Company Initiatives
11.2.3 Sales Analysis

11.3 Sysmex Corporation

11.3.1 Overview
11.3.2 Company Initiatives
11.3.3 Sales Analysis

11.4 Danaher Corporation

11.4.1 Overview
11.4.2 Company Initiatives
11.4.3 Sales Analysis

11.5 Thermo Fischer Scientific

11.5.1 Overview
11.5.2 Company Initiatives
11.5.3 Sales Analysis



List of Figures


Figure-01: Saudi Arabia Population (Million), 2015 – 2020
Figure-02: Forecast for – Saudi Arabia Population (Million), 2021 – 2027
Figure-03: Saudi Arabia Per Capita on Healthcare Expenses (Per Capita US$), 2015 – 2020
Figure-04: Forecast for – Saudi Arabia Per Capita on Healthcare Expenses (Per Capita US$), 2021 – 2027
Figure-05: Saudi Arabia Per Capita on Healthcare Expenditure (Billion US$), 2015 – 2020
Figure-06: Forecast for – Saudi Arabia Per Capita on Healthcare Expenditure (Billion US$), 2021 – 2027
Figure-07: Saudi Arabia IVD Market (Billion US$), 2015 – 2020
Figure-08: Forecast for – Saudi Arabia IVD Market (Billion US$), 2021 – 2027
Figure-09: Segments – Clinical Chemistry Market (Million US$), 2015 – 2020
Figure-10: Segments – Forecast for Clinical Chemistry Market (Million US$), 2021 – 2027
Figure-11: Segments – Immunoassy Market (Million US$), 2015 – 2020
Figure-12: Segments – Forecast for Immunoassy Market (Million US$), 2021 – 2027
Figure-13: Segments – Molecular Diagnostics Market (Million US$), 2015 – 2020
Figure-14: Segments – Forecast for Molecular Diagnostics Market (Million US$), 2021 – 2027
Figure-15: Segments – Hematology Market (Million US$), 2015 – 2020
Figure-16: Segments – Forecast for Hematology Market (Million US$), 2021 – 2027
Figure-17: Segments – Microbiology Market (Million US$), 2015 – 2020
Figure-18: Segments – Forecast for Microbiology Market (Million US$), 2021 – 2027
Figure-19: Segments – Coagulation and Hemostasis Market (Million US$), 2015 – 2020
Figure-20: Segments – Forecast for Coagulation and Hemostasis Market (Million US$), 2021 – 2027
Figure-21: Segments – Urinalysis Market (Million US$), 2015 – 2020
Figure-22: Segments – Forecast for Urinalysis Market (Million US$), 2021 – 2027
Figure-23: Segments – Others Market (Million US$), 2015 – 2020
Figure-24: Segments – Forecast for Others Market (Million US$), 2021 – 2027
Figure-25: Disease – Infectious Market (Million US$), 2015 – 2020
Figure-26: Disease – Forecast for Infectious Market (Million US$), 2021 – 2027
Figure-27: Disease – Cardliology Market (Million US$), 2015 – 2020
Figure-28: Disease – Forecast for Cardliology Market (Million US$), 2021 – 2027
Figure-29: Disease – Diabetes Market (Million US$), 2015 – 2020
Figure-30: Disease – Forecast for Diabetes Market (Million US$), 2021 – 2027
Figure-31: Disease – Cancer/Oncology Market (Million US$), 2015 – 2020
Figure-32: Disease – Forecast for Cancer/Oncology Market (Million US$), 2021 – 2027
Figure-33: Disease – Other Application Market (Million US$), 2015 – 2020
Figure-34: Disease – Forecast for Other Application Market (Million US$), 2021 – 2027
Figure-35: End User – Public Labs & Hospitals Market (Million US$), 2015 – 2020
Figure-36: End User – Forecast for Public Labs & Hospitals Market (Million US$), 2021 – 2027
Figure-37: End User – Private Labs & Hospitals Market (Million US$), 2015 – 2020
Figure-38: End User – Forecast for Private Labs & Hospitals Market (Million US$), 2021 – 2027
Figure-39: End User – Others Market (Million US$), 2015 – 2020
Figure-40: End User – Forecast for Others Market (Million US$), 2021 – 2027
Figure-41: Roche Diagnostics – Global Revenue (Million US$), 2015 – 2020
Figure-42: Roche Diagnostics – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-43: Abbott – Global Revenue (Million US$), 2015 – 2020
Figure-44: Abbott – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-45: Sysmex Corporation – Global Revenue (Million US$), 2015 – 2020
Figure-46: Sysmex Corporation – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-47: Danaher Corporation – Global Revenue (Million US$), 2015 – 2020
Figure-48: Danaher Corporation – Forecast for Global Revenue (Million US$), 2021 – 2027
Figure-49: Thermo Fischer Scientific – Global Revenue (Million US$), 2015 – 2020
Figure-50: Thermo Fischer Scientific – Forecast for Global Revenue (Million US$), 2021 – 2027


List of Tables


Table-01: Saudi Arabia IVD Market Share by Segments (Percent), 2015 – 2020
Table-02: Forecast for – Saudi Arabia IVD Market Share by Segments (Percent), 2021 – 2027
Table-03: Saudi Arabia IVD Market Share by Disease (Percent), 2015 – 2020
Table-04: Forecast for – Saudi Arabia IVD Market Share by Disease (Percent), 2021 – 2027